Post-hoc analysis of MCI186–17, the extension study to MCI186–16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis - Takahashi, F; Takei, K; Tsuda, K (Amyotroph Lateral Scler Frontotemporal Degener, 2017)